What is the gap up history and metrics on VVOS stock?

**Vivos Therapeutics (VVOS) has shown significant volatility following large gap-up moves.** Here's an analysis based on historical data:

1. **Average Performance After Gap-Up Moves**: After the 12 largest gap-up moves over the last 3 years, VVOS stock experienced an average increase of +56.3%. The largest gap-up move was +173.3% on November 29, 2023.

2. **Subsequent Day Performance**: The stock typically saw negative performance the day after a large gap-up move, with an average loss of -7.7%. It was down in 67% of these instances.
3. **Intraday Performance**: The stock experienced a significant gain from the open to the high of the day on November 29, 2023, with a +306.6% increase. The lowest point from the open to the low on March 1, 2023, was a -46.7% drop.
4. **Drift Performance**: The average return from the opening price to the closing price (day drift) for these gap-up moves was +10.3%, with a high of +241.7% on November 29, 2023, and a low of -44.3% on March 1, 2023.
5. **Impact of Press Releases**: Eight of the gap-up moves coincided with company-issued press releases, suggesting that positive news can influence the stock's performance after a gap-up move.

In conclusion, while VVOS tends to perform well in the aftermath of a large gap-up move, the subsequent day often sees negative sentiment, and performance can be quite volatile. The company's press releases and regulatory developments, such as FDA clearances, have a significant impact on the stock's performance.